Hair Care
GLP-1 Drugs and Bone Density
Studies on GLP-1 medication and bone health genuinely disagree with each other. Here is why, and what that means for any...
Our guide to postpartum weight loss covered this period broadly. This article addresses the medication question specifically, since it is frequently the first thing new mothers ask about and deserves direct, clear treatment.
Why GLP-1 medications are not used while breastfeeding
Insufficient safety data on transfer into breast milk and potential effects on a nursing infant is the standard basis for this contraindication, consistent with the pregnancy contraindication covered in our dedicated guide.
This is not a definitive finding of harm, since the data simply does not exist to establish safety with confidence, which is a different, more cautious position than an established danger, but it means the appropriate approach is avoidance until adequate safety data exists, rather than proceeding on the assumption of safety.
Why this period is genuinely temporary
This is worth emphasising, since the restriction can feel indefinite when you are in the middle of it.
Breastfeeding duration varies considerably by individual choice and circumstance, but it is not a permanent state. Once breastfeeding ends, whether at the individually chosen time, the contraindication no longer applies, and appetite support becomes a normal consideration again, covered in our guide to weight loss medicine and pregnancy regarding the broader timeline.
What to do during this specific period
Adequate nutrition matters more, not less. Breastfeeding genuinely increases energy requirements, commonly cited around 500 additional calories daily, so severe restriction during this period is both counterproductive for milk supply and inappropriate given the genuine increased need.
Protein remains valuable, covered in a meta-analysis on appetite hormones, supporting both your own satiety and the tissue demands of continued lactation, without requiring any medication.
Gentle, gradual approaches covered in our postpartum guide, roughly half a kilogram weekly as a sensible ceiling, remain appropriate and achievable without medication during this period.
Sleep, where any control exists, matters considerably, given how directly it affects appetite signalling, though this is often genuinely limited during early parenting regardless of intention.
What this means for planning
If you know you will be breastfeeding for an extended period, and you are considering appetite support for after that period ends, this is worth discussing with your doctor during the breastfeeding period itself, so a plan is in place for when the contraindication lifts, rather than starting that conversation only once breastfeeding has already ended.
This mirrors the pre-conception planning covered in our pregnancy guide: proactive discussion during a contraindicated period, for what happens once it lifts, produces a smoother transition than reactive planning afterward.
Addressing retained weight specifically
Weight retained after pregnancy, once breastfeeding has ended, is treated like weight in any other context, covered in our postpartum guide, and is worth addressing given the health context WHO's obesity fact sheet sets out, including implications for future pregnancies and long-term health.
There is no reason to feel this window has been lost or wasted. The habits established during breastfeeding, adequate nutrition, gentle activity where possible, protein prioritisation, carry forward productively into whatever approach follows once medication becomes an option again.
Common conditions to rule out during this period
Postpartum thyroiditis, covered in our postpartum guide, is common and can cause fatigue and weight changes easily mistaken for ordinary new-parent exhaustion, worth testing for via TSH if symptoms are disproportionate.
Postnatal depression affects appetite and energy and deserves attention in its own right rather than being managed as a weight concern specifically.
Where this leaves the decision
GLP-1 appetite support you hold under the tongue is not used while breastfeeding, consistent with the pharmaceutical medications covered throughout this article. METASLIM™ is a physician-reviewed sublingual supplement, and the physician review process is exactly where breastfeeding status should be disclosed, both to confirm this contraindication applies to your situation and to plan for once breastfeeding ends.
Once you have reached that point, see if you qualify for the program as part of planning your next step.
The summary
GLP-1 medications, including sublingual GLP-1 pathway supplements, are not used while breastfeeding, given insufficient safety data on transfer into breast milk and infant effects.
This restriction is temporary, lifting once breastfeeding ends at whatever point you and your doctor determine appropriate.
Breastfeeding increases energy requirements, making severe restriction both counterproductive for milk supply and inappropriate during this period regardless of medication status.
Adequate protein, gentle gradual approaches, and attention to sleep where possible remain appropriate and valuable during this period without medication.
Discussing plans for after breastfeeding ends, during the breastfeeding period itself, produces a smoother transition than waiting to start that conversation later.
Talk to our team or your own doctor to discuss timing once breastfeeding ends.
This article is for informational purposes only and does not constitute medical advice. Consult a qualified physician before starting any weight loss program, medication, or supplement.